<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
.f1 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff1; src: url("1.ttf"); }
.f2 { font-family:ff1,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff2; src: url("2.ttf"); }
.f3 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
.f4 { font-family:monospace; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="595" height="842" src="page19.png"">
<div class="txt" style="position:absolute; left:253px; top:89px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Ministry of Health - MS</span></div>
<div class="txt" style="position:absolute; left:196px; top:103px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">National Health Surveillance Agency </span><span class="f2" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">– </span><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">ANVISA</span></div>
<div class="txt" style="position:absolute; left:144px; top:131px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">§ 3º The absence of a response to the notification of adequacy referred to</span></div>
<div class="txt" style="position:absolute; left:84px; top:146px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">in the caput within thirty (30) days, counted from its issuance, will cause the</span></div>
<div class="txt" style="position:absolute; left:84px; top:160px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">cancellation of the notification, registration or alteration.</span></div>
<div class="txt" style="position:absolute; left:265px; top:183px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">CHAPTER IV</span></div>
<div class="txt" style="position:absolute; left:224px; top:205px;"><span class="f1" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">ADMINISTRATIVE SANCTIONS</span></div>
<div class="txt" style="position:absolute; left:144px; top:226px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 39. Anvisa may suspend the manufacture, import, marketing and use</span></div>
<div class="txt" style="position:absolute; left:84px; top:242px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">of the medical device in cases where:</span></div>
<div class="txt" style="position:absolute; left:144px; top:263px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">I - The validity of any of the documents referred to in Articles 13 and 14 of</span></div>
<div class="txt" style="position:absolute; left:84px; top:278px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">this Resolution is suspended for reasons of duly justified security;</span></div>
<div class="txt" style="position:absolute; left:144px; top:300px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">II - It is proven that no compliance with any requirement of Chapter III,</span></div>
<div class="txt" style="position:absolute; left:84px; top:315px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Section VII of this Resolution is complied with; or</span></div>
<div class="txt" style="position:absolute; left:144px; top:337px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">III - the product is under investigation by competent health authority,</span></div>
<div class="txt" style="position:absolute; left:84px; top:352px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">regarding the irregularity or defect of the product or manufacturing process, which</span></div>
<div class="txt" style="position:absolute; left:84px; top:367px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">poses a risk to the health of the user, patient, operator or third parties involved, duly</span></div>
<div class="txt" style="position:absolute; left:84px; top:382px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">justified.</span></div>
<div class="txt" style="position:absolute; left:144px; top:403px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 40. The suspension of the manufacture, import, marketing and use of</span></div>
<div class="txt" style="position:absolute; left:84px; top:418px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">medical device will be published in the Official Gazette and will be maintained until the</span></div>
<div class="txt" style="position:absolute; left:84px; top:433px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">solution of the problem that caused the sanction and its annulment is communicated.</span></div>
<div class="txt" style="position:absolute; left:144px; top:455px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 41. Anvisa may cancel the notification or registration of the medical</span></div>
<div class="txt" style="position:absolute; left:84px; top:469px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">device in cases where:</span></div>
<div class="txt" style="position:absolute; left:144px; top:491px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">I - The falsity of information provided in any of the documents requested in</span></div>
<div class="txt" style="position:absolute; left:84px; top:506px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">this Resolution is proven, or any of these documents are canceled by the competent</span></div>
<div class="txt" style="position:absolute; left:84px; top:521px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">health authority;</span></div>
<div class="txt" style="position:absolute; left:144px; top:543px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">II - in case of proof that the product or manufacturing process may</span></div>
<div class="txt" style="position:absolute; left:84px; top:558px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">present a risk to the health of the user, patient, operator or third parties involved;</span></div>
<div class="txt" style="position:absolute; left:144px; top:580px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">III - the absence of information or documents is identified in the</span></div>
<div class="txt" style="position:absolute; left:84px; top:595px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">processes of products subject to notification;</span></div>
<div class="txt" style="position:absolute; left:144px; top:616px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">IV - an error in the health environment is identified in the notification</span></div>
<div class="txt" style="position:absolute; left:84px; top:631px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">procedures; or</span></div>
<div class="txt" style="position:absolute; left:144px; top:653px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">V - When there is no compliance with the demands of procedural</span></div>
<div class="txt" style="position:absolute; left:84px; top:668px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">revaluation presented by Anvisa.</span></div>
<div class="txt" style="position:absolute; left:144px; top:690px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 42. Anvisa may determine the cancellation of changes that cause</span></div>
<div class="txt" style="position:absolute; left:84px; top:705px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">incorrectness of information or irregularity of medical device.</span></div>
<div class="txt" style="position:absolute; left:144px; top:727px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">Art. 43. Anvisa may at its discretion and at any time request information or</span></div>
<div class="txt" style="position:absolute; left:84px; top:741px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(0,0,0,1);">clarifications prior to the decision to cancel irregular notification of medical device.</span></div>
<div class="txt" style="position:absolute; left:145px; top:782px;"><span class="f3" style="font-size:12px;vertical-align:baseline;color:rgba(146,54,52,1);">This text does not replace the published in the Official Gazette.</span></div>
</body>
</html>
